Cargando…

Tyrosine phosphorylation of S1PR1 leads to chaperone BiP-mediated import to the endoplasmic reticulum

Cell surface G protein–coupled receptors (GPCRs), upon agonist binding, undergo serine–threonine phosphorylation, leading to either receptor recycling or degradation. Here, we show a new fate of GPCRs, exemplified by ER retention of sphingosine-1-phosphate receptor 1 (S1PR1). We show that S1P phosph...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwar, Mumtaz, Amin, Md Ruhul, Balaji Ragunathrao, Vijay Avin, Matsche, Jacob, Karginov, Andrei, Minshall, Richard D., Mo, Gary C.H., Komarova, Yulia, Mehta, Dolly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562845/
https://www.ncbi.nlm.nih.gov/pubmed/34652421
http://dx.doi.org/10.1083/jcb.202006021
Descripción
Sumario:Cell surface G protein–coupled receptors (GPCRs), upon agonist binding, undergo serine–threonine phosphorylation, leading to either receptor recycling or degradation. Here, we show a new fate of GPCRs, exemplified by ER retention of sphingosine-1-phosphate receptor 1 (S1PR1). We show that S1P phosphorylates S1PR1 on tyrosine residue Y(143), which is associated with recruitment of activated BiP from the ER into the cytosol. BiP then interacts with endocytosed Y(143)-S1PR1 and delivers it into the ER. In contrast to WT-S1PR1, which is recycled and stabilizes the endothelial barrier, phosphomimicking S1PR1 (Y(143)D-S1PR1) is retained by BiP in the ER and increases cytosolic Ca(2+) and disrupts barrier function. Intriguingly, a proinflammatory, but non-GPCR agonist, TNF-α, also triggered barrier-disruptive signaling by promoting S1PR1 phosphorylation on Y(143) and its import into ER via BiP. BiP depletion restored Y(143)D-S1PR1 expression on the endothelial cell surface and rescued canonical receptor functions. Findings identify Y(143)-phosphorylated S1PR1 as a potential target for prevention of endothelial barrier breakdown under inflammatory conditions.